1. Home
  2. XENE vs RDW Comparison

XENE vs RDW Comparison

Compare XENE & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • RDW
  • Stock Information
  • Founded
  • XENE 1996
  • RDW 2020
  • Country
  • XENE Canada
  • RDW United States
  • Employees
  • XENE N/A
  • RDW N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • RDW Military/Government/Technical
  • Sector
  • XENE Health Care
  • RDW Industrials
  • Exchange
  • XENE Nasdaq
  • RDW Nasdaq
  • Market Cap
  • XENE 2.4B
  • RDW 2.0B
  • IPO Year
  • XENE 2014
  • RDW N/A
  • Fundamental
  • Price
  • XENE $35.99
  • RDW $9.41
  • Analyst Decision
  • XENE Strong Buy
  • RDW Strong Buy
  • Analyst Count
  • XENE 10
  • RDW 7
  • Target Price
  • XENE $53.20
  • RDW $17.50
  • AVG Volume (30 Days)
  • XENE 932.8K
  • RDW 5.4M
  • Earning Date
  • XENE 08-11-2025
  • RDW 08-06-2025
  • Dividend Yield
  • XENE N/A
  • RDW N/A
  • EPS Growth
  • XENE N/A
  • RDW N/A
  • EPS
  • XENE N/A
  • RDW N/A
  • Revenue
  • XENE $7,500,000.00
  • RDW $261,353,000.00
  • Revenue This Year
  • XENE N/A
  • RDW $46.40
  • Revenue Next Year
  • XENE $253.71
  • RDW $44.30
  • P/E Ratio
  • XENE N/A
  • RDW N/A
  • Revenue Growth
  • XENE N/A
  • RDW N/A
  • 52 Week Low
  • XENE $26.74
  • RDW $5.27
  • 52 Week High
  • XENE $46.00
  • RDW $26.66
  • Technical
  • Relative Strength Index (RSI)
  • XENE 69.83
  • RDW 29.36
  • Support Level
  • XENE $32.78
  • RDW $13.10
  • Resistance Level
  • XENE $34.63
  • RDW $15.73
  • Average True Range (ATR)
  • XENE 1.48
  • RDW 1.11
  • MACD
  • XENE 0.45
  • RDW -0.74
  • Stochastic Oscillator
  • XENE 79.01
  • RDW 9.33

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

Share on Social Networks: